-
1.发明授权MACROPOROUS AND HIGHLY RESORBABLE APATITIC CALCIUM-PHOSPHATE CEMENT 有权MAKROPORÖSERUND HOCH RESORBIERBARER APATITISCHER钙钙磷酸盐
公开(公告)号：EP2054090B1
公开(公告)日：2015-10-07
申请号：EP07804808.9
申请日：2007-08-23
申请人： Graftys , UNIVERSITE DE NANTES
CPC分类号： A61L27/46 , A61L24/0036 , A61L24/0042 , A61L24/0063 , A61L24/0084 , A61L27/56 , A61L27/58 , A61L2430/02
-
2.发明公开
公开(公告)号：EP2054090A1
公开(公告)日：2009-05-06
申请号：EP07804808.9
申请日：2007-08-23
申请人： Graftys , UNIVERSITE DE NANTES
CPC分类号： A61L27/46 , A61L24/0036 , A61L24/0042 , A61L24/0063 , A61L24/0084 , A61L27/56 , A61L27/58 , A61L2430/02
摘要： The present invention is directed to a novel cement powder comprising an organic component consisting of one or more biocompatible and bioresorbable polymers and an inorganic component consisting of one or more calcium phosphate compounds. The invention also relates to the apatitic CPC resulting from the mixing of said cement powder with a liquid phase and setting.
-
公开(公告)号：EP2529226B1
公开(公告)日：2017-03-15
申请号：EP11701110.6
申请日：2011-01-25
申请人： INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) , UNIVERSITE DE NANTES , CHU NANTES , Institut Français de Recherche pour l'Exploitation de la Mer - IFREMER
IPC分类号： G01N33/543 , C07F7/18
CPC分类号： G01N33/54353 , A61K9/06 , A61K47/36 , C07F7/1812 , C08B15/05 , C08B37/003 , C08B37/0045 , C08B37/0072 , C08G18/10 , C08G18/12 , C08G18/6446 , C08G18/718 , C08G2210/00 , C08H1/00 , C08H1/06 , C08J3/075 , C08J3/246 , C08J2300/108 , C08J2305/06 , C08J2305/08 , C08L1/08 , C08L1/28 , C08L5/06 , C08L5/08 , C08L89/00 , C08L89/06 , C08L2203/02 , C08G18/3275 , C08L2666/26
-
公开(公告)号：EP1689461A1
公开(公告)日：2006-08-16
申请号：EP04805394.6
申请日：2004-11-04
CPC分类号： C12N5/0655 , A61L27/3817 , A61L27/3852 , C12N2533/30
摘要： The invention relates to the use of a silanised hydroxypropylmethylcellulose (HPMC) or silanised hydroxyethylcellulose (HEC) hydrogel, self-crosslinking as a function of pH, for the three-dimensional ex vivo culture of chondrocytes.
-
5.发明公开SILYLATED BIOMOLECULE-BASED HYDROGEL FOR CULTURING CARDIOMYOCYTES AND STEM CELLS, AND USE OF THE HYDROGEL THEREOF FOR TREATING HEART FAILURE 审中-公开硅烷化BIOMOLEKÜLBASIERTES水凝胶为培养心肌干细胞和水凝胶的用于治疗心力衰竭
公开(公告)号：EP2714891A1
公开(公告)日：2014-04-09
申请号：EP12725754.1
申请日：2012-06-04
申请人： Institut National de la Santé et de la Recherche Médicale (INSERM) , Universite de Nantes , CHU Nantes
摘要： The present invention relates to the use of an hydrogel comprising silylated biomolecule for the three-dimensional culture of cardiomyocytes or stem cells which are able to differentiate into cardiomyocytes, and to an aqueous composition comprising i) cardiomyocytes or stem cells which are able to differentiate into cardiomyocytes, and ii) a hydrogel comprising silylated biomolecule, for use for treating heart failure, in particular heart failure following myocardial infarction.
-
公开(公告)号：EP2529226A1
公开(公告)日：2012-12-05
申请号：EP11701110.6
申请日：2011-01-25
申请人： INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) , UNIVERSITE DE NANTES , CHU NANTES
IPC分类号： G01N33/543 , C07F7/18
CPC分类号： G01N33/54353 , A61K9/06 , A61K47/36 , C07F7/1812 , C08B15/05 , C08B37/003 , C08B37/0045 , C08B37/0072 , C08G18/10 , C08G18/12 , C08G18/6446 , C08G18/718 , C08G2210/00 , C08H1/00 , C08H1/06 , C08J3/075 , C08J3/246 , C08J2300/108 , C08J2305/06 , C08J2305/08 , C08L1/08 , C08L1/28 , C08L5/06 , C08L5/08 , C08L89/00 , C08L89/06 , C08L2203/02 , C08G18/3275 , C08L2666/26
摘要： The invention concerns: - a silylated biomolecule having the following formula (I): - the process for the preparation of a silylated biomolecule of formula (I), - the use of a silylated biomolecule of formula (I) to functionalize the surface of a support, - a process for the preparation of a hydrogel by use of a silylated biomolecule of formula (I), - the hydrogel obtainable by said process, - said hydrogel as a biological tissue substitute, - a composition comprising said hydrogel in a pharmaceutically acceptable vehicle, - said composition for the release of active principle.
摘要翻译： 本发明涉及：具有下式（I）的甲硅烷基化生物分子： - 制备式（I）的甲硅烷基化生物分子的方法， - 使用式（I）的甲硅烷基化生物分子将 支持物，一种通过使用式（I）的甲硅烷基化生物分子制备水凝胶的方法，可通过所述方法获得的水凝胶作为生物组织替代物，包含所述水凝胶在药学上可接受的载体中的组合物 ， - 组合释放活性成分。
-
公开(公告)号：EP1689461B9
公开(公告)日：2007-08-29
申请号：EP04805394.6
申请日：2004-11-04
IPC分类号： A61L27/38
CPC分类号： C12N5/0655 , A61L27/3817 , A61L27/3852 , C12N2533/30
摘要： The invention relates to the use of a silanised hydroxypropylmethylcellulose (HPMC) or silanised hydroxyethylcellulose (HEC) hydrogel, self-crosslinking as a function of pH, for the three-dimensional ex vivo culture of chondrocytes.
-
8.发明授权UTILISATION D'UN HYDROGEL POUR LA CULTURE DE CHONDROCYTES 有权利用德国联合利华水电POUR LA CULTURE DE CHONDROCYTES
公开(公告)号：EP1689461B1
公开(公告)日：2007-05-02
申请号：EP04805394.6
申请日：2004-11-04
IPC分类号： A61L27/38
CPC分类号： C12N5/0655 , A61L27/3817 , A61L27/3852 , C12N2533/30
摘要： The invention relates to the use of a silanised hydroxypropylmethylcellulose (HPMC) or silanised hydroxyethylcellulose (HEC) hydrogel, self-crosslinking as a function of pH, for the three-dimensional ex vivo culture of chondrocytes.
摘要翻译： 本发明涉及作为pH的函数的硅烷化羟丙基甲基纤维素（HPMC）或硅烷化羟乙基纤维素（HEC）水凝胶的自交联用于软骨细胞的三维离体培养的用途。
-
公开(公告)号：EP2714891B1
公开(公告)日：2019-11-13
申请号：EP12725754.1
申请日：2012-06-04
-
-
-
-
-
-
-
-
搜索结果
9 条记录 (耗时 0.015 秒)
